UK markets close in 6 hours 32 minutes

Revolution Medicines, Inc. (RVMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
35.59-0.67 (-1.85%)
At close: 04:00PM EDT
35.11 -0.48 (-1.35%)
After hours: 05:42PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts11111312
Avg. Estimate-0.75-0.78-3.19-3.43
Low estimate-0.85-0.86-3.53-4.11
High estimate-0.67-0.7-2.99-2.36
Year ago EPS-0.72-0.92-3.86-3.19
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10101212
Avg. Estimate1.44M1.48M7.58M6.58M
Low estimateN/AN/AN/AN/A
High estimate8.4M8.82M36.21M44.01M
Year ago sales7.01M3.82M11.58M7.58M
Sales growth (year/est)-79.50%-61.30%-34.50%-13.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.81-0.82-1.01-0.88
Actual EPS-0.72-0.92-0.99-1.14
Difference0.09-0.10.02-0.26
Surprise %11.10%-12.20%2.00%-29.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.75-0.78-3.19-3.43
7 days ago-0.75-0.78-3.19-3.43
30 days ago-0.74-0.77-3.18-3.47
60 days ago-0.77-0.79-3.19-3.04
90 days ago-0.77-0.79-3.26-3.09
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRVMDIndustrySector(s)S&P 500
Current qtr.-4.20%N/AN/AN/A
Next qtr.15.20%N/AN/AN/A
Current year17.40%N/AN/AN/A
Next year-7.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A